Archive


Category: Business Consultant

  • Addressing The Scattered Harbingers of Frontotemporal Dementia

    The present Frontotemporal dementia market comprises of symptomatic medications since no therapy has been approved to help affected patients. However, pharma companies such as TauRx Therapeutics, Axon Neuroscience SE, Prevail Therapeutics, Avid Radiopharmaceuticals, and Alector are actively working to buildup the Frontotemporal dementia pipeline. One of the most diverse groups of neurodegenerative conditions, Frontotemporal dementia […]

  • Metabolic Acidosis: Counting The Unmeasured Anions And Closing the Gap In Blood Serum

    Metabolic Acidosis Market offers immense opportunities to the pharma players to explore, which currently is dominated by alkali therapies and lacks any approved therapy. Launch of Pipeline therapies and rising prevalence shall accelerate the MA market growth in 7MM+3EM by 2030. An acid-base disorder, Metabolic acidosis (MA) is a result of a disturbance in the […]

  • Spot the Signs and Fight Postpartum Depressions

    The Postpartum Depression Market Size in the 7MM was estimated to be USD 138.75 Million in 2017 and is expected to grow further with rise in PPD prevalence and immense opportunities with only a single marketed therapy available. Depression is one of the most common complications of pregnancy. During or after pregnancy, women’s body undergoes […]

  • Rising Nontuberculous Mycobacterial Infection Prevalence Poses A Major Public Health Concern

    The Nontuberculous mycobacterial infection market worth is expected to grow at a CAGR of 6.6% by 2030 owing to robust NTM infection pipeline, rising prevalence among immunocompromised as well as immunocompetent populations, and a considerable shift towards branded therapeutics options. Planet Earth hosts a diversity of microorganisms. According to a new estimate, there exist approximately […]

  • Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline

    As per DelveInsight, the Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30) attributing to a rich pipeline, healthcare spending, improved R&D, and discovery of novel targets. Small cell lung cancer (SCLC) or Small cell lung carcinoma is an aggressive and most malignant form […]